CHEMOS
Oligonucleotide Synthesis, RNA Raw Materials & Modification

5'-O-DMT-2'-O-TBDMS-uridine

Oligonucleotide Synthesis, RNA Raw Materials & Modification

製品番号CH64113CAS番号81246-80-2純度>=98% (HPLC)
製品画像はありません

製品概要

クイックビュー

製品ファミリー
Oligonucleotide Synthesis, RNA Raw Materials & Modification
分子式
C36H44N2O8Si
分子量
660.8
純度
>=98% (HPLC)

5'-O-DMT-2'-O-TBDMS-uridine is uridine carrying a 5'-O-(4,4'-dimethoxytrityl) (DMT) group and a 2'-O-(tert-butyldimethylsilyl) (TBDMS) group. CH64113 is identified by CAS 81246-80-2, molecular formula C36H44N2O8Si, molecular weight 660.8, PubChem CID 11017778, and InChIKey KVHQIELPHWJPSY-WXQJYUTRSA-N.

It is an RNA phosphoramidite precursor: the acid-labile 5'-DMT group is removed at the start of each chain-elongation cycle, and the 2'-O-TBDMS group protects the ribose 2'-hydroxyl during RNA synthesis. Because uracil has no exocyclic amine, no base protecting group is required.

別名

5'-O-DMT-2'-O-TBDMS-uridine; 5'-O-DMT-2'-O-tert-butyldimethylsilyl-rU; DMT-2'-TBDMS-rU

同定情報と仕様

Catalog No.CH64113
CAS No.81246-80-2
Molecular FormulaC36H44N2O8Si
Molecular Weight660.8
PubChem CID11017778
InChIKeyKVHQIELPHWJPSY-WXQJYUTRSA-N
Purity>=98% (HPLC)

保管条件

2-8 C

技術属性

Nucleobase
Uracil
5'-O protection
DMT (dimethoxytrityl)
2'-O protection
TBDMS (tert-butyldimethylsilyl)
Base protection
Unprotected
Packaging
1 g; 2 g; 5 g; 10 g; 25 g; Custom packaging on request
Water content
<=1.0%
Physical form
white to off-white powder

用途情報

  • 5'-DMT 5'-OH protection: the acid-labile 4,4'-dimethoxytrityl group protects the 5'-hydroxyl and is removed at the start of each RNA chain-elongation cycle.
  • 2'-O-TBDMS 2'-OH protection: the tert-butyldimethylsilyl group protects the ribose 2'-hydroxyl during solid-phase RNA synthesis.
  • No base protection needed: uracil has no exocyclic amine, so this building block requires no base protecting group.

関連技術資料

公開情報源

よくある質問

Why does 5'-O-DMT-2'-O-TBDMS-uridine have no base protecting group?

Uracil has no reactive exocyclic amine, so it needs no base protection. Only the 5'-hydroxyl (acid-labile DMT, removed each cycle) and the ribose 2'-hydroxyl (TBDMS, for RNA synthesis) are protected.

How does it differ from 5'-O-DMT-2'-deoxyuridine?

This is the ribonucleoside form with a 2'-hydroxyl protected as a 2'-O-TBDMS ether (for RNA synthesis), whereas the deoxy version has no 2'-OH. The 2'-deoxy form is cataloged separately.

類似製品

材料選択の支援が必要ですか?

CHEMOSは製品適合性、目標構造、ルート上の課題、分析要件、プロジェクト別供給ニーズを確認します。

プロジェクト支援を見る